Balaji Amines Q2 FY27 Results: PAT Surges 82% YoY on Margin Expansion
Balaji Amines Ltd · Investor Presentation · 04 Nov 2026, 5:57 pm
Balaji Amines Q2 FY27 Results: PAT Surges 82% YoY on Margin Expansion Balaji Amines reported strong Q2 FY27 consolidated performance, with revenue growing 35.78% YoY to ₹472 crore. EBITDA surged 58.46% YoY to ₹106 crore, expanding margins to 22%, while PAT rose 81.85% YoY to ₹67 crore. For H1 FY27, consolidated PAT climbed to ₹146 crore from ₹74 crore in H1 FY26. Growth was supported by the operationalization of upgraded Acetonitrile and DME capacities. Management targets 22–23% EBITDA margins for FY27, backed by ongoing capex commissioning at BSCL and upcoming N-Methyl Morpholine projects.
Original exchange filing (PDF)
More announcements from Balaji Amines Ltd
- Submission of Earning Call Transcript under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 · 09 Nov 2026
- Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015-Audio Recording of the Conference Call held on 04th November, 2026 · 05 Nov 2026
- Disclosure under Regulation 30 (2) read with Para A(20) of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirement Regulations) 2015. · 04 Nov 2026
- Press Release in connection with Un-Audited Financial Results of the Company for the Quarter and Half Year Ended 30th September, 2026 · 03 Nov 2026
- Balaji Amines Limited has submitted to the Exchange, Financial Results for the Quarter and Half Year Ended 30th September, 2026 · 03 Nov 2026
- Un-Audited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended 30th September, 2026 · 03 Nov 2026
- Financial Results for the Quarter and Half Year Ended 30th September, 2026 · 02 Nov 2026
- Intimation of Schedule of Conference Call to discuss Q2FY27 Financial Results. · 04 Nov 2026
